SCHEMBL3609826

SCHEMBL3609826

Cc1cc(NCc2ccc(F)cc2)n(C)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.47
HTT P42858 3/20 0.47
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
ATM Q13315 1/20 0.47
HSD17B10 Q99714 1/20 0.47
GPR39 O43194 1/20 0.45
BRD4 O60885 2/20 0.44
KAT2B Q92831 1/20 0.44
ALDH1A1 P00352 1/20 0.43
CYP1A2 P05177 1/20 0.43
GAA P10253 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
HPGD P15428 1/20 0.43
ALOX12 P18054 1/20 0.43
CYP2C19 P33261 1/20 0.43
GFER P55789 1/20 0.43
THRB P10828 1/20 0.43
F2 P00734 4/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13440656 0.87 BRD4 (0.55) KDM4EMEN1KMT2AHSD17B10BRD4
SCHEMBL7272830 0.84 GAA (0.52) KDM4EHTTMEN1KMT2AHSD17B10
SCHEMBL22279102 0.76 HRH4 (0.47) KDM4EHTTMEN1KMT2ABRD4
SCHEMBL5306328 0.76 F2 (0.47) KDM4EHTTMEN1KMT2AALDH1A1
SCHEMBL4682178 0.74 F2 (0.51) KDM4EHTTMEN1KMT2AATM
SCHEMBL4909832 0.72 HTT (0.47) KDM4EHTTMEN1KMT2AGAA
SCHEMBL16946666 0.72 PI4KB (0.56) KDM4EHTTMEN1KMT2AATM
SCHEMBL13106912 0.69 MCHR1 (0.47) KDM4EMEN1KMT2AHSD17B10ALDH1A1
SCHEMBL13106915 0.69 NPC1 (0.46) KDM4EHTTHSD17B10ALDH1A1GAA
SCHEMBL20156432 0.68 SMN1; SMN2 (0.46) KDM4EHTTMEN1KMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100069380-A1 HETEROCYCLIC INHIBITORS OF BACTERIAL PEPTIDYL TRNA HYDROLASE AND USES THEREOF PTC THERAPEUTICS, INC. 2010-03-18 US disclosed
US-20100069380-A1 HETEROCYCLIC INHIBITORS OF BACTERIAL PEPTIDYL TRNA HYDROLASE AND USES THEREOF PTC THERAPEUTICS, INC. 2010-03-18 US disclosed
US-20100069380-A1 HETEROCYCLIC INHIBITORS OF BACTERIAL PEPTIDYL TRNA HYDROLASE AND USES THEREOF PTC THERAPEUTICS, INC. 2010-03-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069380-A1 HETEROCYCLIC INHIBITORS OF BACTERIAL PEPTIDYL TRNA HYDROLASE AND USES THEREOF NSUN3, TARBP1, TRMT1 KDM4E 2676/4885HTT 1095/4885MEN1 4179/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.